Skip to main content
Ferdinand Leya, MD, Cardiology, Maywood, IL, Loyola University Medical Center


Cardiology Maywood, IL

Adult Congenital Heart Disease, Interventional Cardiology

*Professor, Medicine, Loyola University of Chi Stritch School of Medicine *Director, Cardiac Catheterization Lab

Dr. Leya is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Leya's full profile

Already have an account?


  • Fred Leya, MD, an interventional cardiologist, with WJOL radio

    Uploaded by Loyola Medicine on 2015-01-09.

Education & Training

  • Loyola University Medical Center
    Loyola University Medical CenterFellowship, Cardiovascular Disease, 1981 - 1984
  • Columbus HospitalResidency, Internal Medicine, 1978 - 1981
  • Jagiellonian University Medical College
    Jagiellonian University Medical CollegeClass of 1977

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2013 - 2015
  • IL State Medical License
    IL State Medical License 1979 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • Certificate of Honorable Mention for Poster Presentation C3 Complex Cardiovascular Catheter Therapeutics Advanced Endovascular and Coronary Intervention Global Summit, 2016
  • Top Doctors West Suburban Living Magazine, 2014
  • Top Doctors Chicago Magazine, 2014, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations


Journal Articles

  • Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy  
    Sherif F. Nagueh, MD, Bertron M. Groves, MD, Leonard Schwartz, MD, Karen M. Smith, MD, Andrew Wang, MD, Richard G. Bach, MD, Christopher Nielsen, MD, Ferdinand Leya, M..., Journal of American College of Cardiology, 1/1/2011
  • Long-Term Outcomes of Plaque Debulking with Rotational Atherectomy in Side-Branch Ostial Lesions to Treat Bifurction Coronary Disease  
    Hiroki Ito, MD, MS, Sheri Piel, MD, Pranab Das, MD, Vikram Chokar, MD, Ghazanfar Khadim, MD, Robert Nierzwicki, MD, Alexis Willimas, MD, Robert S. Dieter, MD, RVT, Fre..., J Invasive Cardiology, 1/1/2009
  • Femoral Angiogram Prior to Arteriotomy Closure Device Does Not Reduce Vascular Complications in Patients Undergoing Cardiac Catheterization  
    Ravi K. Ramana, D.O., Amandeep Singh, M.D., Robert S. Dieter, M.D., R.V.T., John F. Moran, MD, Lowell Steen, MD, Bruce E. Lewis, MD, and Ferdinand Leya, MD, Journal of Interventional Cardiology, 1/1/2008
  • Join now to see all

Books/Book Chapters

  • Join now to see all


  • Safety and Feasibility of Rotational Atherectomy in Elderly Patients with Calcific Left Main Coronary Artery (LMCA) Disease undergoing PCI: A Retrospective Observation...
    Falak Shah, Mahmoud Khreis, Mohamad Hani Lababidi, Amani Sharma, Amir Darki, Bruce E. Lewis, Ferdinand Leya, John J. Lopez, Lowell H. Steen, Jr., 12th Annual Complex Cardiovascular Catheter Therapeutics (C3): Advanced Endovascular and Coronary Intervention Global Summit, Orlando, FL, 1/28/2016
  • The Utility of Ankle-Brachial Index (ABI) in Risk Stratifying Patients Undergoing Evaluation for Coronary Artery Disease (CAD).
    Falak Shah, Jessica Pillarella, Robert S. Dieter, Bruce E. Lewis, Ferdinand Leya, John J. Lopez, Conner O'Keefe, Ivan V. Pacold, Lowell H. Steen, Jr., Ami Darki, SCAI 2016 Scientific Session, 1/1/2016
  • Can Ccta Derived Lvot Area Reclassify Aortic Stenosis Using the Continuity Equation?
    Rajeev Ruben Fernando, Taishi, Hirai, Syed, MushabbarA., Leya, Fred Sanagala, Thriveni, Dajani, Khaled A, 1/1/2015
  • Join now to see all


  • Effect of Cardiopulmonary Support on Regional and Global LV Function During Transient Coronary Occlusion. 


  • Toxicological and safety aspects of Low Molecular Weight Heparin (Sandoparin (R)) used over a 12 week period with daily subcutaneous administration in subhuman primates. 
    Bacher P, Lojewski B, Iqbal O, Hoppensteadt D, Walenga JM, Leya F, Pifarre R, Fareed J, FDA

Professional Memberships

Other Languages

  • Polish

Hospital Affiliations